Article info
PDFPulmonary hypertension
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
- Correspondence to:
Dr O Sitbon
Centre des Maladies Vasculaires Pulmonaires, Hôpital Antoine Béclère, Université Paris-Sud, 157 rue de la Porte de Trivaux, 92141 Clamart, France; olivier.sitbonabc.aphp.fr
Citation
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
Publication history
- Received January 19, 2005
- Accepted July 3, 2005
- First published July 29, 2005.
Online issue publication
September 01, 2022
Article Versions
- Previous version (7 March 2017).
- Previous version (15 April 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 Thorax